talipexole has been researched along with Disease Models, Animal in 7 studies
talipexole: dopamine receptor agonist; structure given in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined whether or not the antiparkinsonian activity of talipexole (B-HT 920, 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]-azepine) could be optimised by combination with L-3,4-dihydroxyphenylalanine (L-dopa)." | 1.29 | Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment. ( Fukuda, T; Irifune, M; Nomoto, M, 1994) |
| "These findings show that cataplexy may be regulated by D2/D3 dopaminergic receptors in the ventral tegmental area and perhaps the globus pallidus/ putamen." | 1.29 | Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine. ( Mignot, E; Nishino, S; Reid, MS; Sampathkumaran, R; Siegel, JM; Tafti, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Johansen, FF | 1 |
| Hasseldam, H | 1 |
| Rasmussen, RS | 1 |
| Bisgaard, AS | 1 |
| Bonfils, PK | 1 |
| Poulsen, SS | 1 |
| Hansen-Schwartz, J | 1 |
| Tsuchioka, A | 1 |
| Oana, F | 1 |
| Suzuki, T | 1 |
| Yamauchi, Y | 1 |
| Ijiro, T | 1 |
| Kaidoh, K | 1 |
| Hiratochi, M | 1 |
| Irifune, M | 1 |
| Nomoto, M | 1 |
| Fukuda, T | 1 |
| Reid, MS | 1 |
| Tafti, M | 1 |
| Nishino, S | 1 |
| Sampathkumaran, R | 1 |
| Siegel, JM | 1 |
| Mignot, E | 1 |
| George, B | 1 |
| Kulkarni, SK | 1 |
| Kitamura, Y | 1 |
| Kakimura, J | 1 |
| Taniguchi, T | 1 |
7 other studies available for talipexole and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia.
Topics: Animals; Azepines; Blotting, Western; Brain Ischemia; Disease Models, Animal; Dopamine Agonists; Hyp | 2014 |
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions.
Topics: Animals; Antiparkinson Agents; Apomorphine; Azepines; Benzothiazoles; Cabergoline; Corpus Striatum; | 2015 |
Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; A | 1994 |
Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine.
Topics: Amygdala; Animals; Azepines; Cataplexy; Disease Models, Animal; Dogs; Dopamine; Dopamine Agents; Dop | 1996 |
Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzazepines; Disease | 1997 |
Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Azepines; Brain; Disease Models, Animal; Dopa | 1998 |